Sei Investments Co. trimmed its holdings in shares of Monsanto Company (NYSE:MON) by 10.5% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 192,890 shares of the basic materials company’s stock after selling 22,616 shares during the quarter. Sei Investments Co.’s holdings in Monsanto were worth $23,113,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also modified their holdings of MON. Global X Management Co. LLC increased its position in shares of Monsanto by 20.8% during the first quarter. Global X Management Co. LLC now owns 3,584 shares of the basic materials company’s stock valued at $406,000 after acquiring an additional 617 shares during the last quarter. MARSHALL WACE ASIA Ltd purchased a new stake in shares of Monsanto during the first quarter valued at approximately $63,977,000. Guardian Life Insurance Co. of America increased its position in shares of Monsanto by 0.7% during the first quarter. Guardian Life Insurance Co. of America now owns 1,689 shares of the basic materials company’s stock valued at $191,000 after acquiring an additional 11 shares during the last quarter. Marshall Wace North America L.P. purchased a new stake in shares of Monsanto during the first quarter valued at approximately $21,277,000. Finally, Yakira Capital Management Inc. purchased a new stake in shares of Monsanto during the first quarter valued at approximately $1,132,000. 74.50% of the stock is owned by institutional investors.
WARNING: “Monsanto Company (MON) Shares Sold by Sei Investments Co.” was originally published by TrueBlueTribune and is the property of of TrueBlueTribune. If you are viewing this report on another website, it was illegally copied and republished in violation of U.S. and international copyright law. The original version of this report can be accessed at https://www.truebluetribune.com/2017/11/14/monsanto-company-mon-shares-sold-by-sei-investments-co.html.
Shares of Monsanto Company (MON) opened at $118.15 on Tuesday. Monsanto Company has a 12-month low of $97.44 and a 12-month high of $122.79. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.83 and a current ratio of 1.35. The firm has a market capitalization of $52,075.66, a PE ratio of 21.39, a price-to-earnings-growth ratio of 1.70 and a beta of 1.05.
Monsanto (NYSE:MON) last released its quarterly earnings results on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.41) by $0.61. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The business had revenue of $2.69 billion for the quarter, compared to the consensus estimate of $2.51 billion. During the same quarter last year, the business posted $0.07 earnings per share. The company’s revenue for the quarter was up 4.8% on a year-over-year basis. equities research analysts forecast that Monsanto Company will post 5.74 EPS for the current fiscal year.
In other news, VP Duraiswami Narain sold 2,860 shares of Monsanto stock in a transaction dated Monday, September 25th. The stock was sold at an average price of $120.00, for a total value of $343,200.00. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, EVP Steven Mizell sold 11,526 shares of Monsanto stock in a transaction dated Monday, October 9th. The stock was sold at an average price of $119.70, for a total value of $1,379,662.20. The disclosure for this sale can be found here. Insiders have sold 49,236 shares of company stock worth $5,931,934 in the last 90 days. Company insiders own 0.79% of the company’s stock.
Several brokerages have weighed in on MON. Zacks Investment Research lowered Monsanto from a “buy” rating to a “hold” rating in a report on Tuesday, September 5th. BMO Capital Markets reissued a “buy” rating and set a $128.00 price objective on shares of Monsanto in a report on Friday, September 1st. BidaskClub raised Monsanto from a “sell” rating to a “hold” rating in a report on Saturday, August 19th. Vetr lowered Monsanto from a “buy” rating to a “hold” rating and set a $122.35 price objective for the company. in a report on Wednesday, August 2nd. Finally, Barclays PLC reissued an “equal weight” rating and set a $124.00 price objective (up from $120.00) on shares of Monsanto in a report on Thursday, October 5th. Eleven research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Monsanto currently has a consensus rating of “Hold” and an average price target of $124.61.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.